Performance of a Fast-track Pathway for Giant Cell Arteritis Diagnosis

Recruiting Observational Study
Giant Cell Arteritis (GCA)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Groupe Hospitalier de la Rochelle Ré Aunis · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Giant cell arteritis is a vasculitis, i.e. inflammation of the artery walls, which generally affects people over the age of 50. Diagnosis can be long and difficult, as the clinical signs are not specific (headache, pain in the jaw, scalp, shoulders and/or pelvis, abdominal pain, weight loss, etc.), but it must be made quickly, given the risk of complications. The reference method for diagnosis wa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient suspected of GCA Exclusion Criteria: * Opposition to the use of their data
Contacts

Caroline Allix-Béguec, Ph.D.

+33516494246

caroline.allix-beguec@ght-atlantique17.fr

CONTACT

Cécile Duchiron, Ph.D.

cecile.duchiron@ght-atlantique17.Fr

CONTACT